AMBALALSA Stock View

Ambalal Sarabhai Enterprises Ltd

AMBALALSA Stock View

(BSE)

Trade

1.75 | 5.00

Market Cap ₹( Cr.)
2,807.08

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
17-Sep-2023

 

Copy Link

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data